Investor buzz around cannabis stocks with new treatments

Last week ASX-listed Zelira Therapeutics, formerly Zelda Therapeutics, scored a new substantial shareholder when billionaire investor Alex Waislitz’s Thorney Investment Group upped its stake from 2 per cent to 5.2 per cent. Earlier this month Zelira confirmed its cannabinoid insomnia medicine Zenivol had been made available in Australia under the ... Read More

Schultze Special Purpose Acquisition Corp. and Clever Leaves International Inc., a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator, to Participate in Two Upcoming Investor Conferences

/EIN News/ — RYE BROOK, N.Y., Sept. 24, 2020 (GLOBE NEWSWIRE) — Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”) today announced that the companies will participate in two upcoming investor conferences. On Wednesday, September 30, 2020, the companies will ... Read More